Farah Ballout

729 total citations
30 papers, 530 citations indexed

About

Farah Ballout is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Farah Ballout has authored 30 papers receiving a total of 530 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 12 papers in Oncology and 6 papers in Surgery. Recurrent topics in Farah Ballout's work include Cancer Cells and Metastasis (7 papers), Nigella sativa pharmacological applications (6 papers) and Bioactive Compounds and Antitumor Agents (5 papers). Farah Ballout is often cited by papers focused on Cancer Cells and Metastasis (7 papers), Nigella sativa pharmacological applications (6 papers) and Bioactive Compounds and Antitumor Agents (5 papers). Farah Ballout collaborates with scholars based in United States, Lebanon and Italy. Farah Ballout's co-authors include Wassim Abou‐Kheir, Alissar Monzer, Hala Gali‐Muhtasib, Hisham F. Bahmad, Deborah Mukherji, Reda Chalhoub, Ola Hadadeh, Albert El Hajj, Katia Cheaito and Georges Daoud and has published in prestigious journals such as Gastroenterology, PLoS ONE and Cancer Research.

In The Last Decade

Farah Ballout

28 papers receiving 528 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Farah Ballout United States 13 229 181 110 84 76 30 530
Alissar Monzer Lebanon 10 211 0.9× 203 1.1× 37 0.3× 88 1.0× 37 0.5× 20 460
Shijie Fan China 12 299 1.3× 96 0.5× 75 0.7× 69 0.8× 16 0.2× 31 518
Zujun Que China 16 251 1.1× 155 0.9× 54 0.5× 134 1.6× 14 0.2× 35 551
Melissa Rodríguez United States 10 382 1.7× 143 0.8× 208 1.9× 39 0.5× 156 2.1× 23 688
Nashwa Kabil United States 12 307 1.3× 147 0.8× 40 0.4× 155 1.8× 29 0.4× 19 540
Chengguang Zhao China 15 285 1.2× 147 0.8× 28 0.3× 106 1.3× 36 0.5× 52 609
Nermin Kahraman United States 16 686 3.0× 151 0.8× 50 0.5× 373 4.4× 41 0.5× 32 913
Shengchao Lin China 11 296 1.3× 74 0.4× 56 0.5× 201 2.4× 12 0.2× 12 497
Rachana Trivedi India 8 388 1.7× 146 0.8× 24 0.2× 98 1.2× 53 0.7× 11 560

Countries citing papers authored by Farah Ballout

Since Specialization
Citations

This map shows the geographic impact of Farah Ballout's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Farah Ballout with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Farah Ballout more than expected).

Fields of papers citing papers by Farah Ballout

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Farah Ballout. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Farah Ballout. The network helps show where Farah Ballout may publish in the future.

Co-authorship network of co-authors of Farah Ballout

This figure shows the co-authorship network connecting the top 25 collaborators of Farah Ballout. A scholar is included among the top collaborators of Farah Ballout based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Farah Ballout. Farah Ballout is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bhat, Nadeem S., Mohammed Soutto, Farah Ballout, et al.. (2025). Enhancing the antitumor efficacy using a combination of FGFR4 Inhibitor (H3B-6527) and oxaliplatin in gastric cancer. Neoplasia. 71. 101257–101257.
2.
Chen, Lei, Heng Lu, Farah Ballout, et al.. (2025). Targeting NEK Kinases in Gastrointestinal Cancers: Insights into Gene Expression, Function, and Inhibitors. International Journal of Molecular Sciences. 26(5). 1992–1992. 1 indexed citations
3.
Monzer, Alissar, Farah Ballout, Samar Al Bitar, et al.. (2024). ONC206, an imipridone derivative, demonstrates anti-colorectal cancer activity against stem/progenitor cells in 3D cell cultures and in patient-derived organoids. Pharmacological Reports. 77(1). 229–246. 3 indexed citations
4.
Ballout, Farah, Heng Lu, Nadeem S. Bhat, et al.. (2024). Targeting SMAD3 Improves Response to Oxaliplatin in Esophageal Adenocarcinoma Models by Impeding DNA Repair. Clinical Cancer Research. 30(10). 2193–2205. 2 indexed citations
5.
Bhat, Nadeem S., et al.. (2024). Esophageal adenocarcinoma models: a closer look. Frontiers in Molecular Biosciences. 11. 1440670–1440670.
6.
Lu, Heng, Farah Ballout, Abbes Belkhiri, et al.. (2023). Reflux conditions induce E-cadherin cleavage and EMT via APE1 redox function in oesophageal adenocarcinoma. Gut. 73(1). 47–62. 17 indexed citations
7.
Chen, Lei, Farah Ballout, Heng Lu, et al.. (2023). Differential Expression of NEK Kinase Family Members in Esophageal Adenocarcinoma and Barrett’s Esophagus. Cancers. 15(19). 4821–4821. 5 indexed citations
8.
Lu, Heng, Long‐Long Cao, Farah Ballout, et al.. (2023). Tu1268 REFLUX CONDITIONS-INDUCED E-CADHERIN CLEAVAGE AND EPITHELIAL-TO-MESENCHYMAL TRANSITION IS MEDIATED BY APE1 REDOX FUNCTION IN ESOPHAGEAL ADENOCARCINOMA. Gastroenterology. 164(6). S–1011. 1 indexed citations
9.
Chen, Lei, Heng Lu, Dunfa Peng, et al.. (2022). Activation of NOTCH signaling via DLL1 is mediated by APE1-redox-dependent NF-κB activation in oesophageal adenocarcinoma. Gut. 72(3). 421–432. 19 indexed citations
10.
Monzer, Alissar, Farah Ballout, Samar Al Bitar, et al.. (2022). Novel therapeutic diiminoquinone exhibits anticancer effects on human colorectal cancer cells in two-dimensional and three-dimensional in vitro models. World Journal of Gastroenterology. 28(33). 4787–4811. 4 indexed citations
11.
Ballout, Farah, Heng Lu, Lei Chen, et al.. (2022). APE1 redox function is required for activation of Yes-associated protein 1 under reflux conditions in Barrett’s-associated esophageal adenocarcinomas. Journal of Experimental & Clinical Cancer Research. 41(1). 264–264. 13 indexed citations
12.
Assi, Sahar, Hisham F. Bahmad, Reda Chalhoub, et al.. (2020). Correction to: The potential use of tideglusib as an adjuvant radio-therapeutic treatment for glioblastoma multiforme cancer stem-like cells. Pharmacological Reports. 73(1). 316–316. 2 indexed citations
13.
Bahmad, Hisham F., Reda Chalhoub, Hayat Harati, et al.. (2020). Tideglusib attenuates growth of neuroblastoma cancer stem/progenitor cells in vitro and in vivo by specifically targeting GSK-3β. Pharmacological Reports. 73(1). 211–226. 24 indexed citations
14.
Ballout, Farah, et al.. (2020). Cancerona: Challenges of Cancer Management in Times of COVID-19 Pandemic. SN Comprehensive Clinical Medicine. 2(11). 2005–2014. 2 indexed citations
15.
16.
17.
Çapcı, Aysun, Pithi Chanvorachote, Julienne K. Muenzner, et al.. (2019). Combination of 5-fluorouracil and thymoquinone targets stem cell gene signature in colorectal cancer cells. Cell Death and Disease. 10(6). 379–379. 57 indexed citations
18.
Ballout, Farah, Zeina Habli, Omar Nasser Rahal, Maamoun Fatfat, & Hala Gali‐Muhtasib. (2018). Thymoquinone-based nanotechnology for cancer therapy: promises and challenges. Drug Discovery Today. 23(5). 1089–1098. 54 indexed citations
19.
Bahmad, Hisham F., Katia Cheaito, Reda Chalhoub, et al.. (2018). Sphere-Formation Assay: Three-Dimensional in vitro Culturing of Prostate Cancer Stem/Progenitor Sphere-Forming Cells. Frontiers in Oncology. 8. 347–347. 156 indexed citations
20.
Nemer, Georges, Rémi Safi, Firas Kreidieh, et al.. (2017). Understanding the phenotypic similarities between IFAP and Olmsted syndrome from a molecular perspective: the interaction of MBTPS2 and TRPV3. Archives of Dermatological Research. 309(8). 637–643. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alissar Monzer Breakdown of academic impact, for papers by Shijie Fan Breakdown of academic impact, for papers by Zujun Que Breakdown of academic impact, for papers by Melissa Rodríguez Breakdown of academic impact, for papers by Nashwa Kabil Breakdown of academic impact, for papers by Chengguang Zhao Breakdown of academic impact, for papers by Nermin Kahraman Breakdown of academic impact, for papers by Shengchao Lin Breakdown of academic impact, for papers by Rachana Trivedi
Rankless by CCL
2026